A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of AK112 in the Treatment of Advanced Gynecological Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Dose Escalation and Expansion Study of AK117
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of AK104 Plus Anlotinib in NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AK112 for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2